Active Biotech AB publ
F:BTPC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Active Biotech AB publ
F:BTPC
|
SE |
|
F
|
Flowserve Corp
XMUN:FWV
|
US |
|
D
|
DR Horton Inc
XMUN:HO2
|
US |
|
M
|
Mondelez International Inc
F:KTF
|
US |
|
W
|
Wilmar International Ltd
F:RTHA
|
SG |
|
Aegon NV
F:AEND
|
NL |
|
S
|
SLM Corp
DUS:SM1
|
US |
|
T
|
Talanx AG
XMUN:TLX
|
DE |
|
M
|
Mercer International Inc
F:AEZ
|
CA |
|
G
|
GEN Restaurant Group Inc
NASDAQ:GENK
|
US |
|
C
|
Commercial Metals Co
SWB:CMS
|
US |
|
Strongpoint ASA
F:PGT
|
NO |
|
S
|
Star Entertainment Group Ltd
F:EE9
|
AU |
|
P
|
PagerDuty Inc
F:2TY
|
US |
|
C
|
Cerner Corp
F:CRE
|
US |
|
T
|
Trillion Energy International Inc
OTC:TRLEF
|
CA |
|
L
|
Leggett & Platt Inc
F:LP1
|
US |
Wall St Price Targets
BTPC Price Targets Summary
Active Biotech AB publ
According to Wall Street analysts, the average 1-year price target for BTPC is 0.0285 EUR with a low forecast of 0.0282 EUR and a high forecast of 0.0293 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BTPC's stock price target?
Price Target
0.0285
EUR
According to Wall Street analysts, the average 1-year price target for BTPC is 0.0285 EUR with a low forecast of 0.0282 EUR and a high forecast of 0.0293 EUR.